Burke M. A.,Cook S.A.,Seidman J.G.,Seidman C.E. . (2016). . .Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy. Journal of the American College of Cardiology, : 2871-2886.
Chaulin A. M.,Duplyakov D. V. J. J. o. C. P. .2020 .Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 2 (literature review), 11(4) : 70-82.
Debold E. P.,Schmitt J. P.,Patlak J.,Beck S.,Moore J.,Seidman J. G.,Physiology C. .2007 .Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse α-cardiac myosin in the laser trap assay. , 293(1) : H284-H291.
Duplyakov D.,Chaulin A. J. C. .2019 .Mutations of heart troponines, associated with cardiomyopathies. , 7(3) : 8-17.
Elliott P.,Andersson B.,Arbustini E.,Bilinska Z.,Cecchi F.,Charron P.,McKenna W. J. J. E. h. j. .2008 .Classification of the cardiomyopathies: a position statement from the. European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases, 29(2) : 270-276.
Elliott P. M.,Anastasakis A.,Borger M. A.,Borggrefe M.,Cecchi F.,Charron P.,Mahrholdt H. J. K. P. .2014 .2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. , 72(11) : 1054-1126.
Gangadharan B.,Sunitha M. S.,Mukherjee S.,Chowdhury R. R.,Haque F.,Sekar N.,Mercer J. A. J. P. o. t. N. A. o. S. .2017 .Molecular mechanisms and structural features of cardiomyopathycausing troponin T mutants in the tropomyosin overlap region. , 114(42) : 11115-11120.
Gao G.,Chen G.,Tong W.,Mao Y.,Liu C.,Yang J.,P. J. M. J. .2020 .A novel nonsense mutation in TNNT2 in a Chinese pedigree with hypertrophic cardiomyopathy: A case report. , 99(34) : .
Hershberger R. E.,Hedges D. J.,Morales A. J. N. R. C. .2013 .Dilated cardiomyopathy: the complexity of a diverse genetic architecture. , 10(9) : 531-547.
Hershberger R. E.,Siegfried J. D. J. J. o. t. A. C. o. C. .2011 .Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. , 57(16) : 1641-1649.
Hitomi N.,Kubo T.,Kitaoka H.,Hirota T.,Hamada T.,Hoshikawa E.,Doi Y. L. J. J. o. c. .2010 .A frameshift deletion mutation in the cardiac myosin-binding protein C gene associated with dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. , 56(2) : 189-196.
Huke S.,Venkataraman R.,Faggioni M.,Bennuri S.,Hwang H. S.,Baudenbacher F.,Knollmann B. C. J. C. .2013 .Focal energy deprivation underlies arrhythmia susceptibility in mice with calciumsensitized myofilaments. , 112(10) : 1334-1344.
Kramer C. M.,Appelbaum E.,Desai M. Y.,Desvigne-Nickens P.,DiMarco J. P.,Friedrich M. G.,Jerosch-Herold M. J. A. . .. , : .
.2015 .Hypertrophic Cardiomyopathy Registry: the rationale and design of an international, observational study of hypertrophic cardiomyopathy. , 170(2) : 223-230.
Landstrom A. P.,Ackerman M. J. J. C. .2010 .Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy. , 122(23) : 2441-2450.
Lee S.,Pahl E. J. P. i. P. C. .2021 .Optimal imaging strategy for surveillance in children with hypertrophic cardiomyopathy. , 63 : 101432.
J. B. R. I. .2013 .TNNT2 gene polymorphisms are associated with susceptibility to idiopathic dilated cardiomyopathy in the Han Chinese population. , : .
Lipshultz S. E.,Law Y. M.,Asante-Korang A.,Austin E. D.,Dipchand A. I.,Everitt M. D.,Wilkinson J. D. J. C. .2019 .. , : .
. .Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American Heart Association. , 140(1) : e9-e68.
Lüscher T. F. J. E. H. J. .2016 .Cardiomyopathies: definition, diagnosis, causes, and genetics. In, 37 : 1779-1782.
Marian A,Rooij E.,Roberts R. J. J. o. t. A. C. o. C. .2016 .. , : .
. .Genetics and genomics of single-gene cardiovascular diseases: common hereditary cardiomyopathies as prototypes of single-gene disorders. , 68(25) : 2831-2849.
Maron B. J.,Bonow R. O.,Cannon III,Leon R. O.,Epstein M. B.,S. E. J. N. E. J. o. M. M. B. .1987 .Hypertrophic cardiomyopathy. , 316(14) : 844-852.
Marston S.,Copeland O. N.,Gehmlich K.,Schlossarek S.,Carrrier L. J. J. o. m. .2012 .How do MYBPC3 mutations cause hypertrophic cardiomyopathy. , 33(1) : 75-80.
McConnell M.,Grinspan Tal,Williams L.,Lynn M. R.,Schwartz M. L.,Fass B. A.,Tardiff O. Z.,J. C. J. B. O. Z. .2017 .Clinically divergent mutation effects on the structure and function of the human cardiac tropomyosin overlap. , 56(26) : 3403-3413.
McNally E. M. a. M.,L. . E. M. a. M. .2017 .. Dilated Cardiomyopathy. Circulation Research, 731 : 748.
Mehta M. D.,Marwah S. A.,Ghosh S.,Shah H. N.,Trivedi A. P.,Haridas N. J. J. o. F. M.,Care P. .2015 .A synergistic role of ischemia modified albumin and high-sensitivity troponin T in the early diagnosis of acute coronary syndrome. , 4(4) : 570.
J. P. i. p. c. .2014 .Genetic causes of dilated cardiomyopathy. , 37(1- 2) : 13-18.
.2014 .Allosteric effects of cardiac troponin TNT1 mutations on actomyosin binding: a novel pathogenic mechanism for hypertrophic cardiomyopathy. , 552 : 21-28.
Nanni L.,Pieroni M.,Chimenti C.,Simionati B.,Zimbello R.,Maseri A. .2003 .Hypertrophic cardiomyopathy: two homozygous cases with “typical” hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy. , 309(2) : 391-398.
Paldino A.,De Angelis G.,Merlo M.,Gigli M.,Ferro Dal,Severini M.,Sinagra G.,G. J. C. C. R. G. .2018 .Genetics of dilated cardiomyopathy: clinical implications. , 20(10) : 1-13.
Rani D. S.,Nallari P.,Priyamvada S.,Narasimhan C.,Singh L.,Thangaraj K. J. B. m. g. .2012 .High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians. , 13(1) : 1-8.
Roberts A. M.,Ware J. S.,Herman D. S.,Schafer S.,Baksi J.,Bick A. G.,Wilkinson S. J. S. t. m. .2015 .Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. , 7(270) : 270ra276-270ra276.
.2007 .Dilated and hypertrophic cardiomyopathy mutations in troponin and α-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments. , 101(12) : 1266-1273.
Park C. B. J. C. .2014 .Perturbation of NCOA6 leads to dilated cardiomyopathy. , 8(4) : 991-998.
Rani Selvi,Nallari D.,Dhandapany P.,Tamilarasi P. S.,Shah S.,Archana A.,V. A. .2012 .Cardiac Troponin T (TNNT2) mutations are less prevalent in Indian hypertrophic cardiomyopathy patients. , 31(4) : 616-624.
Tadros H. J.,Life C. S.,Garcia G.,Pirozzi E.,Jones E. G.,Datta S. .2020 .Meta-analysis of cardiomyopathyassociated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes. , 142 : 118-125.
McKenna J.,W. J. J. C. J. .2001 .Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. , 104(12) : 1380-1384.
Veselka J.,Anavekar N. S.,Charron P. J. T. L. .2017 .. , : .
. .Hypertrophic obstructive cardiomyopathy. , 389(10075) : 1253-1267.
Villard E.,Perret C.,Gary F.,Proust C.,Dilanian G.,Hengstenberg C.,Germain M. J. E. h. j. .2011 .A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. , 32(9) : 1065-1076.
Witjas-Paalberends E. R.,Güçlü A.,Germans T.,Knaapen P.,Harms H. J.,Vermeer A. M.,Lammertsma A. A. J. C. .2014 .. , : .